日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials

研究总结：Delgocitinib乳膏治疗中重度慢性手部湿疹成人患者的疗效和安全性（DELTA 1和DELTA 2）：多中心、随机、对照、双盲3期试验结果

期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-025-00974-4
Bissonnette, Robert; Albreiki, Fatima; Ehst, Benjamin D; Al Hammadi, Anwar; Schliemann, Sibylle; Yang, Bin; Zhang, Jianzhong; Bunick, Christopher G
发表日期：2026
文献求助 收藏

Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 Trials

更正：研究总结：Delgocitinib乳膏治疗中重度慢性手部湿疹成人患者的疗效和安全性（DELTA 1和DELTA 2）：来自多中心、随机、对照、双盲3期试验的结果

期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-025-00989-x
Bissonnette, Robert; Albreiki, Fatima; Ehst, Benjamin D; Al Hammadi, Anwar; Schliemann, Sibylle; Yang, Bin; Zhang, Jianzhong; Bunick, Christopher G
发表日期：2026
文献求助 收藏

Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16

在 UnlIMMited 4 期随机临床试验第 16 周时，Risankizumab 治疗生殖器或头皮银屑病的疗效和安全性

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01544-6
Song, Eingun James; Ehst, Benjamin; Glick, Brad; Lewitt, George Michael; Rich, Phoebe; Ezra, Navid; Bagel, Jerry; Anschutz, Toni; Bialik, Brenton; Duan, Chenyang; Ashley, Doug; Patel, Manish; St John, Greg; Setty, Arathi R; Ackerman, Lindsay
银屑病
多发性骨髓瘤
发表日期：2026
文献求助 收藏

Exploring Two New, Validated Disease-Specific Outcome Measures to Assess Severity of Chronic Hand Eczema: Investigator Global Assessment of Chronic Hand Eczema (IGA-CHE) and Hand Eczema Symptom Diary (HESD)-A Podcast

探索两种新的、经过验证的疾病特异性结局指标来评估慢性手部湿疹的严重程度：研究者对慢性手部湿疹的总体评估 (IGA-CHE) 和手部湿疹症状日记 (HESD)——播客

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01551-7
Chovatiya, Raj; Ehst, Benjamin; Silverberg, Jonathan
发表日期：2026
文献求助 收藏

Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States

美国慢性手部湿疹诊断和治疗的专家建议

期刊:American Journal of Clinical Dermatology
影响因子:
doi:10.1007/s40257-026-01008-3
Silverberg, Jonathan I; Cohen, David; Guttman-Yassky, Emma; Eichenfield, Lawrence F; Simpson, Eric L; Armstrong, April; Yu, JiaDe; Stein-Gold, Linda; Ehst, Benjamin D; Begolka, Wendy Smith; Bunick, Christopher G; Chovatiya, Raj
发表日期：2026
文献求助 收藏

A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab

一项随机 II 期临床试验，旨在评估使用高剂量利沙珠单抗治疗中重度斑块状银屑病患者的疗效。

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-67475-0
Blauvelt, Andrew; Jiang, Rundong; Shi, Linyu; Tsoi, Lam C; Bogle, Rachael; Fox, Jennifer; Gharaee-Kermani, Mehrnaz; Billi, Allison C; Matheson, Robert T; Photowala, Huzefa; Gudjonsson, Johann E; Ehst, Benjamin D
银屑病
发表日期：2025
文献求助 收藏

Health-Related Quality of Life in Chronic Hand Eczema in a Phase 2b Trial of Delgocitinib Cream

Delgocitinib乳膏治疗慢性手部湿疹的2b期临床试验中，患者的健康相关生活质量情况

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01384-4
Buhl, Timo; Bauer, Andrea; Ehst, Benjamin D; Thyssen, Jacob P; Hahn-Pedersen, Julie; Hagen, Berith Fredsted; Apol, Eydna D; Agner, Tove
发表日期：2025
文献求助 收藏

A randomized, double-blinded, phase 2 trial of EDP1815, an oral immunomodulatory preparation of Prevotella histicola, in adults with mild-to-moderate plaque psoriasis

一项针对轻度至中度斑块状银屑病成年患者的随机、双盲、2期临床试验，研究了口服免疫调节剂Prevotella histicola（组织普雷沃氏菌）EDP1815的疗效。

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2024.1292406
Ehst, Benjamin D; Strober, Bruce; Blauvelt, Andrew; Maslin, Douglas; Macaro, Debbie; Carpenter, Nancy; Bodmer, Mark; McHale, Duncan
银屑病
免疫/内分泌
发表日期：2024
文献求助 收藏

Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review

IL-23 p19抑制剂治疗中重度斑块状银屑病患者的安全性：一项叙述性综述

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-023-02568-0
Blauvelt, Andrew; Chiricozzi, Andrea; Ehst, Benjamin D; Lebwohl, Mark G
银屑病
IL-23
IL-2
发表日期：2023
文献求助 收藏

The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial

一项为期 16 周的随机 IIb 期试验表明，乳膏剂型的泛 JAK 抑制剂 delgocitinib 对慢性手部湿疹具有剂量反应关系。

期刊:British Journal of Dermatology
影响因子:9.6
doi:10.1111/bjd.21037
Worm, Margitta; Thyssen, Jacob P; Schliemann, Sibylle; Bauer, Andrea; Shi, Vivian Y; Ehst, Ben; Tillmann, Sandra; Korn, Sofie; Resen, Katarina; Agner, Tove
JAK/STAT
发表日期：2022
文献求助 收藏